Antibodies binding the TNF related protein, TNF-X
US7060800B2 · kind B2 · utility
27Cited by
1References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 7, 2001 |
| Grant date | Jun 13, 2006 |
| Priority date | — |
| Expiry date | Nov 20, 2022 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/975
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Nucleic acids encoding mammalian, e.g., primate or rodent, genes, purified proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.